Loading...
TruScreen Group Limited
TRU.AX•ASX
Healthcare
Medical - Devices
A$0.02
A$0.00(0.00%)
TruScreen Group Limited (TRU.AX) Financial Performance & Income Statement Overview
Review TruScreen Group Limited (TRU.AX) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
56.51%
↑ 56.51%
Operating Income Growth
37.07%
↑ 37.07%
Net Income Growth
14.63%
↑ 14.63%
Operating Cash Flow Growth
7.32%
↑ 7.32%
Operating Margin
-60.56%
↓ 60.56%
Gross Margin
49.12%
↑ 49.12%
Net Profit Margin
-68.03%
↓ 68.03%
ROE
-69.09%
↓ 69.09%
ROIC
-69.30%
↓ 69.30%
TruScreen Group Limited (TRU.AX) Income Statement & Financial Overview
Analyze TruScreen Group Limited’s TRU.AX earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $1.25M | $1.44M | $1.16M | $532395.00 |
| Cost of Revenue | $736232.00 | $630776.00 | $806871.00 | $322742.00 |
| Gross Profit | $509766.00 | $809792.00 | $357063.00 | $209653.00 |
| Gross Profit Ratio | $0.41 | $0.56 | $0.31 | $0.39 |
| R&D Expenses | $393058.00 | $336681.00 | $540622.00 | $184435.00 |
| SG&A Expenses | $1.16M | $1.06M | $1.08M | $564291.00 |
| Operating Expenses | $1.55M | $1.39M | $1.62M | $801673.00 |
| Total Costs & Expenses | $2.29M | $2.02M | $2.43M | $1.12M |
| Interest Income | $0.00 | $0.00 | $0.00 | $1263.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $33959.00 | $581911.00 | $1.27M | $108391.00 |
| EBITDA | -$1.01M | $0.00 | $0.00 | -$430682.00 |
| EBITDA Ratio | -$0.81 | $0.00 | $0.00 | -$0.81 |
| Operating Income | -$1.04M | -$581911.00 | -$1.27M | -$539073.00 |
| Operating Income Ratio | -$0.84 | -$0.40 | -$1.09 | -$1.01 |
| Other Income/Expenses (Net) | -$296909.00 | -$112255.00 | -$89300.00 | -$51684.00 |
| Income Before Tax | -$1.34M | -$694166.00 | -$1.36M | -$590757.00 |
| Income Before Tax Ratio | -$1.08 | -$0.48 | -$1.17 | -$1.11 |
| Income Tax Expense | -$208426.00 | $0.00 | $0.00 | -$96518.00 |
| Net Income | -$1.13M | -$694166.00 | -$1.36M | -$590757.00 |
| Net Income Ratio | -$0.91 | -$0.48 | -$1.17 | -$1.11 |
| EPS | -$0.002 | -$0.002 | -$0.003 | -$0.002 |
| Diluted EPS | -$0.002 | -$0.002 | -$0.003 | -$0.002 |
| Weighted Avg Shares Outstanding | $539.75M | $420.71M | $423.86M | $369.69M |
| Weighted Avg Shares Outstanding (Diluted) | $539.75M | $420.49M | $423.86M | $369.47M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan